Duality Biotherapeutics Inc Forecast, price target & analysts
Why the stock moved Beta
Duality Biotherapeutics Inc Target price 2026 - Analyst rating & recommendation
Duality Biotherapeutics Inc Classifications & Recommendation
Duality Biotherapeutics Inc Price Target
| Target Price | HK$466.90 |
| Price | HK$211.40 |
| Potential |
120.86%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Duality Biotherapeutics Inc 2027 .
The average Duality Biotherapeutics Inc target price is HK$466.90.
This is
120.86%
register free of charge
HK$573.95
171.50%
register free of charge
HK$287.35
35.92%
register free of charge
|
|
| A rating was issued by 13 analysts: 12 Analysts recommend Duality Biotherapeutics Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Duality Biotherapeutics Inc stock has an average upside potential 2027 of
120.86%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 2.17 | 1.97 |
| 4.61% | 9.17% | |
| EBITDA Margin | -24.16% | -38.55% |
| 136.93% | 59.57% | |
| Net Margin | -140.13% | -29.74% |
| 158.97% | 78.78% |
9 Analysts have issued a sales forecast Duality Biotherapeutics Inc 2026 . The average Duality Biotherapeutics Inc sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Duality Biotherapeutics Inc EBITDA forecast 2026. The average Duality Biotherapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Duality Biotherapeutics Inc Analysts have issued a net profit forecast 2026. The average Duality Biotherapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | -33.98 | -6.55 |
| 129.75% | 80.72% | |
| P/E | negative | |
| EV/Sales | 6.57 |
9 Analysts have issued a Duality Biotherapeutics Inc forecast for earnings per share. The average Duality Biotherapeutics Inc EPS is
This results in the following potential growth metrics and future valuations:
Duality Biotherapeutics Inc...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
